CMF-00332 | COL6A3 | up-regulates | JUN | activates | R-211 | 25 | 4 | Drugs (7) |
CMF-00364 | COL6A3 | up-regulates | PLAG1 | activates | R-2508 | 5 | 4 | Drugs (4) |
CMF-00579 | HMCN1 | up-regulates | EGR1 | activates | R-996 | 20 | 10 | Drugs (2) |
CMF-00609 | HMCN1 | up-regulates | JUN | activates | R-211 | 25 | 14 | Drugs (7) |
CMF-00614 | HMCN1 | down-regulates | SP4 | represses | R-2346 | 8 | 4 | Drugs (45) Regulator Drugs (0)Regulon Drugs (45)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-00721 | HMCN1 | up-regulates | SMAD1 | activates | R-1484 | 21 | 7 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-01103 | ZNF292 | down-regulates | SPI1 | activates | R-373 | 25 | 12 | Drugs (47) Regulator Drugs (0)Regulon Drugs (47)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, DASATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, REGORAFENIB, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-01154 | ZNF292 | down-regulates | PLAG1 | activates | R-2508 | 5 | 2 | Drugs (4) |
CMF-01472 | MTOR | down-regulates | SP4 | represses | R-2346 | 8 | 1 | Drugs (45) Regulator Drugs (0)Regulon Drugs (45)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-01804 | TMPRSS15 | up-regulates | EGR1 | activates | R-996 | 20 | 5 | Drugs (2) |
CMF-02010 | TCHH | down-regulates | PITX1 | activates | R-2472 | 3 | 1 | Drugs (3) |
CMF-02249 | GPR65 | up-regulates | SMAD3 | activates | R-2538 | 15 | 2 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-02714 | ABCA5 | up-regulates | SMAD3 | activates | R-2538 | 15 | 2 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-02731 | ABCA5 | up-regulates | SMAD1 | activates | R-1484 | 21 | 1 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-03440 | ZNF28 | down-regulates | JUN | activates | R-211 | 25 | 3 | Drugs (7) |
CMF-04139 | KIAA2026 | up-regulates | SP4 | represses | R-2346 | 8 | 1 | Drugs (45) Regulator Drugs (0)Regulon Drugs (45)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-04915 | ABCC5 | down-regulates | IRF7 | activates | R-2475 | 21 | 9 | Drugs (6) |
CMF-05755 | ADAMTS19 | down-regulates | TP53 | activates | R-1773 | 13 | 1 | Drugs (4) |
CMF-06173 | MDGA2 | down-regulates | SP4 | represses | R-2346 | 8 | 1 | Drugs (45) Regulator Drugs (0)Regulon Drugs (45)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-06795 | ATRX | down-regulates | IRF7 | activates | R-2475 | 21 | 19 | Drugs (6) |
CMF-06841 | ATRX | down-regulates | EGR1 | activates | R-996 | 20 | 12 | Drugs (2) |
CMF-07526 | ANO7 | down-regulates | TP53 | activates | R-1773 | 13 | 5 | Drugs (4) |
CMF-08460 | MSL3 | down-regulates | PITX1 | activates | R-2472 | 3 | 1 | Drugs (3) |
CMF-08478 | MSL3 | down-regulates | JUN | activates | R-211 | 25 | 7 | Drugs (7) |
CMF-08594 | FOXR2 | down-regulates | EGR1 | activates | R-996 | 20 | 5 | Drugs (2) |
CMF-09027 | NALCN | down-regulates | JUN | activates | R-211 | 25 | 7 | Drugs (7) |
CMF-09068 | FLT1 | down-regulates | SPI1 | activates | R-373 | 25 | 2 | Drugs (47) Regulator Drugs (0)Regulon Drugs (47)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, DASATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, REGORAFENIB, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-09070 | FLT1 | down-regulates | IRF7 | activates | R-2475 | 21 | 3 | Drugs (6) |
CMF-09350 | SPTA1 | down-regulates | SMAD1 | activates | R-1484 | 21 | 2 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-09426 | ZIC4 | up-regulates | JUN | activates | R-211 | 25 | 2 | Drugs (7) |
CMF-09456 | ZIC4 | up-regulates | SMAD1 | activates | R-1484 | 21 | 2 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-09476 | DOCK11 | up-regulates | TP53 | activates | R-1773 | 13 | 2 | Drugs (4) |
CMF-10055 | ATP8A2 | up-regulates | SP4 | represses | R-2346 | 8 | 2 | Drugs (45) Regulator Drugs (0)Regulon Drugs (45)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-10100 | TACR3 | down-regulates | SPI1 | activates | R-373 | 25 | 3 | Drugs (47) Regulator Drugs (0)Regulon Drugs (47)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, DASATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, REGORAFENIB, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-10116 | PCDHGA8 | down-regulates | IRF7 | activates | R-2475 | 21 | 2 | Drugs (6) |
CMF-10516 | LRBA | up-regulates | EGR1 | activates | R-996 | 20 | 7 | Drugs (2) |
CMF-10568 | LRBA | up-regulates | SMAD1 | activates | R-1484 | 21 | 5 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-11395 | CYP4F22 | up-regulates | TP53 | activates | R-1773 | 13 | 4 | Drugs (4) |
CMF-11841 | SKIV2L | down-regulates | SP4 | represses | R-2346 | 8 | 1 | Drugs (45) Regulator Drugs (0)Regulon Drugs (45)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-12262 | GPR98 | down-regulates | SPI1 | activates | R-373 | 25 | 13 | Drugs (47) Regulator Drugs (0)Regulon Drugs (47)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, DASATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, REGORAFENIB, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-12306 | GPR98 | down-regulates | ZFX | activates | R-793 | 23 | 8 | Drugs (8) |
CMF-12376 | GPR98 | down-regulates | PLAG1 | activates | R-2508 | 5 | 3 | Drugs (4) |
CMF-12934 | HTR3E | down-regulates | JUN | activates | R-211 | 25 | 10 | Drugs (7) |
CMF-13068 | OTC | up-regulates | SPI1 | activates | R-373 | 25 | 3 | Drugs (47) Regulator Drugs (0)Regulon Drugs (47)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, DASATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, REGORAFENIB, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-13644 | FMN1 | up-regulates | SMAD1 | activates | R-1484 | 21 | 11 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-13781 | ADAMTS8 | down-regulates | SPI1 | activates | R-373 | 25 | 12 | Drugs (47) Regulator Drugs (0)Regulon Drugs (47)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, DASATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, REGORAFENIB, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-13786 | ADAMTS8 | down-regulates | EGR1 | activates | R-996 | 20 | 3 | Drugs (2) |
CMF-13794 | ADAMTS8 | down-regulates | JUN | activates | R-211 | 25 | 7 | Drugs (7) |
CMF-14133 | CD1D | up-regulates | SPI1 | activates | R-373 | 25 | 5 | Drugs (47) Regulator Drugs (0)Regulon Drugs (47)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, DASATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, REGORAFENIB, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-14388 | SLC4A1 | down-regulates | SP4 | represses | R-2346 | 8 | 1 | Drugs (45) Regulator Drugs (0)Regulon Drugs (45)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-14485 | PRKCD | down-regulates | EGR1 | activates | R-996 | 20 | 4 | Drugs (2) |
CMF-15274 | HCN1 | up-regulates | EGR1 | activates | R-996 | 20 | 11 | Drugs (2) |
CMF-15281 | HCN1 | down-regulates | SP4 | represses | R-2346 | 8 | 2 | Drugs (45) Regulator Drugs (0)Regulon Drugs (45)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-15653 | DCHS2 | up-regulates | JUN | activates | R-211 | 25 | 9 | Drugs (7) |
CMF-15701 | DCHS2 | up-regulates | SMAD1 | activates | R-1484 | 21 | 4 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-15790 | GRM3 | up-regulates | IRF7 | activates | R-2475 | 21 | 7 | Drugs (6) |
CMF-15795 | GRM3 | up-regulates | JUN | activates | R-211 | 25 | 1 | Drugs (7) |
CMF-15820 | GRM3 | up-regulates | SMAD1 | activates | R-1484 | 21 | 1 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-16618 | KRTAP5-4 | up-regulates | SMAD1 | activates | R-1484 | 21 | 2 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-16997 | FLNA | down-regulates | SPI1 | activates | R-373 | 25 | 2 | Drugs (47) Regulator Drugs (0)Regulon Drugs (47)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, DASATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, REGORAFENIB, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-17085 | A2BP1 | down-regulates | IRF7 | activates | R-2475 | 21 | 2 | Drugs (6) |
CMF-17593 | ODZ1 | down-regulates | TP53 | activates | R-1773 | 13 | 5 | Drugs (4) |
CMF-17619 | ODZ1 | down-regulates | SMAD3 | activates | R-2538 | 15 | 3 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-17686 | MRPL32 | down-regulates | PLAG1 | activates | R-2508 | 5 | 1 | Drugs (4) |
CMF-18516 | LAMA1 | up-regulates | SMAD1 | activates | R-1484 | 21 | 6 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-18702 | MPP7 | down-regulates | IRF7 | activates | R-2475 | 21 | 6 | Drugs (6) |
CMF-18722 | MPP7 | down-regulates | SMAD1 | activates | R-1484 | 21 | 5 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-19310 | NF1 | up-regulates | EGR1 | activates | R-996 | 20 | 10 | Drugs (2) |
CMF-19362 | NF1 | up-regulates | JUN | activates | R-211 | 25 | 16 | Drugs (7) |
CMF-19365 | NF1 | down-regulates | SP4 | represses | R-2346 | 8 | 3 | Drugs (45) Regulator Drugs (0)Regulon Drugs (45)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-19428 | NF1 | up-regulates | SMAD3 | activates | R-2538 | 15 | 7 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-19597 | NF1 | up-regulates | PLAG1 | activates | R-2508 | 5 | 4 | Drugs (4) |
CMF-19615 | USP6 | down-regulates | PITX1 | activates | R-2472 | 3 | 1 | Drugs (3) |
CMF-20271 | ENAM | down-regulates | JUN | activates | R-211 | 25 | 4 | Drugs (7) |
CMF-20272 | ENAM | up-regulates | SP4 | represses | R-2346 | 8 | 1 | Drugs (45) Regulator Drugs (0)Regulon Drugs (45)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-21131 | COL22A1 | down-regulates | PITX1 | activates | R-2472 | 3 | 1 | Drugs (3) |
CMF-21157 | ADAM30 | up-regulates | PITX1 | activates | R-2472 | 3 | 1 | Drugs (3) |
CMF-21165 | ADAM30 | down-regulates | SP4 | represses | R-2346 | 8 | 2 | Drugs (45) Regulator Drugs (0)Regulon Drugs (45)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-21262 | EGR1 | up-regulates | SMAD3 | activates | R-2538 | 15 | 3 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-21430 | GRIK3 | up-regulates | SMAD1 | activates | R-1484 | 21 | 4 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-22145 | PDGFRA | down-regulates | SPI1 | activates | R-373 | 25 | 9 | Drugs (47) Regulator Drugs (0)Regulon Drugs (47)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, DASATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, REGORAFENIB, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-22435 | IDH1 | down-regulates | IRF7 | activates | R-2475 | 21 | 20 | Drugs (6) |
CMF-22487 | IDH1 | down-regulates | EGR1 | activates | R-996 | 20 | 13 | Drugs (2) |
CMF-23224 | RNF17 | up-regulates | JUN | activates | R-211 | 25 | 8 | Drugs (7) |
CMF-23322 | PABPC3 | down-regulates | JUN | activates | R-211 | 25 | 2 | Drugs (7) |
CMF-23347 | CCDC132 | up-regulates | SMAD1 | activates | R-1484 | 21 | 4 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-23717 | TP53 | down-regulates | SPI1 | activates | R-373 | 25 | 15 | Drugs (47) Regulator Drugs (0)Regulon Drugs (47)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, DASATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, REGORAFENIB, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-23791 | TP53 | up-regulates | SP4 | represses | R-2346 | 8 | 5 | Drugs (45) Regulator Drugs (0)Regulon Drugs (45)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-24082 | TP53 | down-regulates | SMAD1 | activates | R-1484 | 21 | 12 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-24507 | SEMA3C | down-regulates | SMAD3 | activates | R-2538 | 15 | 6 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-24562 | SEMA3C | down-regulates | SMAD1 | activates | R-1484 | 21 | 6 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-24781 | HIST1H2BE | up-regulates | PITX1 | activates | R-2472 | 3 | 1 | Drugs (3) |
CMF-25220 | CPNE7 | up-regulates | SMAD3 | activates | R-2538 | 15 | 1 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-25444 | PCDHGB3 | up-regulates | SMAD3 | activates | R-2538 | 15 | 4 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-26315 | CHGB | up-regulates | EGR1 | activates | R-996 | 20 | 4 | Drugs (2) |
CMF-26997 | HMCN1 | up-regulates | JUN | activates | R-211 | 25 | 2 | Drugs (7) |
CMF-27742 | C21orf29 | down-regulates | IRF7 | activates | R-2475 | 21 | 1 | Drugs (6) |
CMF-28077 | CELSR3 | down-regulates | JUN | activates | R-211 | 25 | 9 | Drugs (7) |
CMF-28455 | MYO9B | down-regulates | PLAG1 | activates | R-2508 | 5 | 4 | Drugs (4) |
CMF-28673 | PCNX | down-regulates | SMAD1 | activates | R-1484 | 21 | 3 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-28762 | MLL4 | down-regulates | EGR1 | activates | R-996 | 20 | 4 | Drugs (2) |
CMF-28766 | MLL4 | down-regulates | JUN | activates | R-211 | 25 | 4 | Drugs (7) |
CMF-29069 | DNAH3 | up-regulates | SMAD3 | activates | R-2538 | 15 | 1 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-29138 | FOLH1B | down-regulates | PLAG1 | activates | R-2508 | 5 | 2 | Drugs (4) |
CMF-29194 | AQP10 | down-regulates | SPI1 | activates | R-373 | 25 | 8 | Drugs (47) Regulator Drugs (0)Regulon Drugs (47)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, DASATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, REGORAFENIB, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-29208 | AQP10 | up-regulates | SP4 | represses | R-2346 | 8 | 3 | Drugs (45) Regulator Drugs (0)Regulon Drugs (45)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-29259 | NEU2 | down-regulates | IRF7 | activates | R-2475 | 21 | 2 | Drugs (6) |
CMF-29494 | SEMA3E | up-regulates | JUN | activates | R-211 | 25 | 7 | Drugs (7) |
CMF-29627 | ESRRB | down-regulates | EGR1 | activates | R-996 | 20 | 11 | Drugs (2) |
CMF-29647 | ESRRB | down-regulates | JUN | activates | R-211 | 25 | 4 | Drugs (7) |
CMF-29872 | ABCC9 | up-regulates | JUN | activates | R-211 | 25 | 8 | Drugs (7) |
CMF-30060 | FAM126B | down-regulates | SP4 | represses | R-2346 | 8 | 2 | Drugs (45) Regulator Drugs (0)Regulon Drugs (45)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-30374 | RNF130 | down-regulates | SPI1 | activates | R-373 | 25 | 5 | Drugs (47) Regulator Drugs (0)Regulon Drugs (47)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, DASATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, OCRIPLASMIN, AEE-788, PYROTINIB, TAK-285, REGORAFENIB, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-30385 | RNF130 | down-regulates | SMAD1 | activates | R-1484 | 21 | 3 | Drugs (41) Regulator Drugs (0)Regulon Drugs (41)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, AFATINIB DIMALEATE, CP-724714, AFATINIB, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GANCOTAMAB |
CMF-31513 | EGF_RECEPTOR_SIGNALING_PATHWAY | up-regulates | TP53 | activates | R-1773 | 13 | 6 | Drugs (4) |
CMF-32781 | E_CADHERIN_SIGNALING_IN_KERATINOCYTES | up-regulates | TP53 | activates | R-1773 | 13 | 7 | Drugs (4) |
CMF-33303 | ERBB1_DOWNSTREAM_SIGNALING | up-regulates | TP53 | activates | R-1773 | 13 | 7 | Drugs (4) |